Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 6/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 5/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 4/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | GBA1 | P04062 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31037710 | 1.00 | ABCG2 (0.33) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL31037697 | 0.91 | TP53 (0.36) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL23855846 | 0.91 | TP53 (0.36) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL23855823 | 0.89 | ALDH1A1 (0.34) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL31037693 | 0.89 | ALDH1A1 (0.34) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL30709642 | 0.83 | ABCG2 (0.36) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL21888576 | 0.82 | MEN1 (0.39) | MEN1KMT2AHPGDALDH1A1MAPT | |
| SCHEMBL23914547 | 0.81 | ABCG2 (0.38) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL23914548 | 0.81 | ABCG2 (0.38) | ABCG2MEN1KMT2ARAB9ATP53 | |
| SCHEMBL26292529 | 0.80 | MEN1 (0.40) | ABCG2MEN1KMT2ARAB9ATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | KYULUX, INC. (JP) | 2021-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210305517-A1 | COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES | OPRD1, DRD1, DRD3 | ABCG2 2195/4885MEN1 3613/4885KMT2A 2610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.